MedTrace Logo

Comparative Head Lice Therapy With Dimet 5® vs. Hedrin® Once

NCT04878276 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 240

Last updated 2024-03-06

No results posted yet for this study

Summary

Randomized, investigator-blinded, controlled, multicenter comparative study on the treatment of acute head lice infestation in children with 2 dimeticone preparations with different application times and compositions: Dimet 5® (100% dimeticone) versus Hedrin® Once Liquid Gel (4% dimeticone + nerolidol) with treatment success assessment via freedom from infestation of live head lice at final examination at V2, i.e. day 19 after first treatment.

Conditions

  • Head Lice Infestation
  • Pediculosis Capitis
  • Lice

Interventions

DEVICE

Dimet 5

The application is carried out according to the enclosed instructions for use.

Sponsors & Collaborators

  • Infectopharm Arzneimittel GmbH

    lead INDUSTRY

Eligibility

Min Age
6 Months
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-17
Primary Completion
2026-03-31
Completion
2026-03-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04878276 on ClinicalTrials.gov